Pharmacist Medication Insights: Phesgo for HER2-Positive Breast Cancer
July 26th 2021The combination of pertuzumab, trastuzumab and hyaluronidase–zzxf is indicated for adult patients with HER2-positive breast cancer that has spread to other parts of the body and for adult patients with early HER2-positive breast cancer.
Read More
Pharmacist Medication Insights: Tecartus for Mantle Cell Lymphoma
July 15th 2021Brexucabtagene autoleucel (Tecartus, Kite Pharma) is a cell-based gene therapy for the treatment of adult patients with mantle cell lymphoma who have not responded to or who have relapsed following other treatments.
Read More
Pharmacist Medication Insights: Margetuximab for Metastatic HER2-Positive Breast Cancer
July 13th 2021Margetuximab-cmkb (Margenza) was approved in December 2020 in combination with chemotherapy for the treatment of adult patients with metastatic HER2-positive breast cancer who have previously received 2 or more anti-HER2 regimens, at least one of which for metastatic disease.
Read More